Merit Medical Systems (MMSI) Q4 FY25 earnings call

Merit Medical Systems delivered a strong Q4 FY25, surpassing revenue and profitability expectations with record gross margins and robust free cash flow generation. The company provided solid FY26 guidance, aligning with its multi-year growth initiatives, while navigating headwinds from OEM destocking, China's VBP, and tariff impacts. The new CEO is focused on strategic planning around product platforms and disciplined M&A to drive future growth.